Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

被引：0
|
作者：
Egeberg, Alexander [1 ]
Pinter, Andreas [2 ]
Vender, Ronald [3 ]
Zaheri, Shirin [4 ]
Brnabic, Alan [5 ]
Schuster, Christopher [5 ,6 ]
Elrayes, Mohamed [5 ]
Reed, Catherine [5 ]
Riedl, Elisabeth [6 ]
Puig, Luis [7 ]
机构：
[1] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[2] Univ Hosp Frankfurt, Clin Dermatol Venereol & Allergol, Frankfurt, Germany
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] HCA Healthcare, London, England
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[7] Univ Autonoma Barcelona, Dept Dermatol, IIB SANT PAU, Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42592
引用
下载
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [1] Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO
    Riedl, Elisabeth
    Pinter, Andreas
    Zaheri, Shirin
    Costanzo, Antonio
    Brnabic, Alan
    Konicek, Bruce
    McKenzie, Robert
    Lampropoulou, Anastasia
    Rayes, Mohamed El
    Haustrup, Natalie
    Schuster, Christopher
    DERMATOLOGY AND THERAPY, 2024, 14 (05) : 1327 - 1335
  • [2] Baseline characteristics and comorbid conditions in patients with moderate-to-severe plaque psoriasis enrolled in the Psoriasis Study of Health Outcomes (PSoHO)
    Puig, Lluis
    Reich, Adam
    Zaheri, Shirin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB23 - AB23
  • [3] Initial report on the Month 12 results from the Psoriasis Study of Health Outcomes (PSoHO) for patients with moderate-to-severe psoriasis treated with biologics in the real-world setting
    Costanzo, Antonio
    Paul, Carle
    Carrascosa, Jose Manuel
    Tada, Yayoi
    Brnabic, Alan
    Schuster, Christopher
    Reed, Catherine
    Abrahamy, Michael
    Riedl, Elisabeth
    Pinter, Andreas
    Mahar, Patrick
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 26 - 26
  • [4] Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
    Armstrong, April W.
    Riedl, Elisabeth
    Brunner, Patrick M.
    Piaserico, Stefano
    Visser, Willie I.
    Haustrup, Natalie
    Konicek, Bruce W.
    Kadziola, Zbigniew
    Nunez, Mercedes
    Brnabic, Alan
    Schuster, Christopher
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [5] INTERIM ANALYSIS OF BASELINE CHARACTERISTICS AND 12-WEEK OUTCOMES FOR A SUBSET OF PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND PSORIATIC ARTHRITIS FROM THE PSORIASIS STUDY OF HEALTH OUTCOMES
    Kristensen, L. E.
    Behrens, F.
    Puig, L.
    Reich, A.
    Holzkaemper, T.
    Brnabic, A.
    Ng, K.
    Leage, S. Liu
    Schuster, C.
    Pinter, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1562 - 1562
  • [6] Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)
    Piaserico, Stefano
    Riedl, Elisabeth
    Pavlovsky, Lev
    Vender, Ronald B.
    Mert, Can
    Tangsirisap, Nithi
    Haustrup, Natalie
    Gallo, Gaia
    Schuster, Christopher
    Brunner, Patrick M.
    FRONTIERS IN MEDICINE, 2023, 10
  • [7] Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
    Travaglini, Massimo
    Maul, Julia -Tatjana
    Kors, Christian
    Zaheri, Shirin
    Gerwien, Jens
    Mueller, Michaela
    Brnabic, Alan
    Sabatino, Silvia
    Schuster, Christopher
    Tsai, Tsen-Fang
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2971 - 2983
  • [8] Understanding comorbidities and concomitant medication patterns in patients with moderate- to-severe plaque psoriasis in the real-world Psoriasis Study of Health Outcomes (PSoHO)
    Puig, Luis
    Schaekel, Knut
    Reich, Adam
    Zaheri, Shirin
    Tjioe, Milan
    Brnabic, Alan
    de Hoog, Niek
    Reed, Catherine
    Schuster, Christopher
    Riedl, Elisabeth
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB245 - AB245
  • [9] Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
    Pinter, Andreas
    Eyerich, Kilian
    Costanzo, Antonio
    Garrelts, Alyssa
    Schuster, Christopher
    Mert, Can
    Lampropoulou, Anastasia
    Fotiou, Konstantinos
    Maul, Julia-Tatjana
    Papp, Kim A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [10] Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Characteristics of Psoriasis Patients at the Beginning of the PROSPECT Study
    Korber, A.
    von Kiedrowski, R.
    Kraehn-Senftleben, G.
    Schwinn A
    Hagemeier, H. H.
    Bachhuber, T.
    Kasparek, T.
    Amon, U.
    Augustin, M.
    Thaci, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 137 - 138
12345